(EMAILWIRE.COM, July 31, 2017 ) According to Publisher, the Global Multiplex Assays market is accounted for $2.68 billion in 2015 and is expected to reach $4.7 billion by 2022 growing at a CAGR of 8.1% from 2015 to 2022. Growing demand for high throughput and automated systems will offer a significant growth opportunity over the forecast period. Some factors such as rising safety & efficacy of therapies, growing advantages of multiplexing over conventional assays and improving validation for biomarkers are contributing the market growth. However, huge capital investments and shortage of skilled labour are negatively affecting the market.

R&D segment registered a largest market share during the forecast period attributed to easy and closer grades offered by multiple assays. North America commanded the largest market share followed by Europe. Furthermore, Asia Pacific is expected to grow at a fastest rate during the forecast period.

For more information http://www.reportsweb.com/multiplex-assays-global-market-outlook-2016-2022 .

Some of the key vendors participated in this market include Randox Laboratories Ltd., Seegene Inc., Becton, Dickinson and Company, Qiagen N.V., Illumina, Inc., Luminex Corporation, Meso Scale Diagnostics, LLC, Merck KGAA, Abcam PLC, Bio-Rad Laboratories Inc. and Thermo Fisher Scientific Inc.

Technologies Covered:
- Multiplex Arrays
o Multiplex Bead-Based Array
o Multiplex Planar Arrays
- Multiplex Pcr
- Other Technologies

Product and Services Covered:
- Multiplex Assay Accessories
- Multiplex Assay Consumables
- Multiplex Assay Instruments
- Software and Services

End User Covered:
- Hospitals
- Academic & Research Institutes
- Clinical Laboratories
- Pharmaceutical & Biotechnology Companies
- Other End Users

Assays Types Covered:
- Protein-Based Multiplex Assays
o Bead-Based Protein Assays
o Planar Protein Assays
- Nucleic Acid-Based Multiplex Assays
o Bead-Based Nucleic Acid Assays
o Planar Nucleic Acid Assays

Application Covered:
- Companion Diagnostics
- Research & Development
o Biomarker Discovery and Validation
o Drug Development
- Diseases & Disorders
o Allergies
o Autoimmune Diseases
o Cancer
o Alzheimer’s Disease
o Infectious Diseases
o Cardiac Diseases

Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

Request Sample Copy: http://www.reportsweb.com/inquiry&RW0001564964/sample

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

12 Company Profiling
12.1 Randox Laboratories Ltd.
12.2 Seegene Inc.
12.3 Becton, Dickinson and Company
12.4 Qiagen N.V.
12.5 Illumina, Inc.
12.6 Luminex Corporation
12.7 Meso Scale Diagnostics, LLC
12.8 Merck KGAA
12.12 Abcam PLC
12.10 Bio-Rad Laboratories Inc.
12.11 Thermo Fisher Scientific Inc.

Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564964/buying .

Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results